2-tert-Butyl-4-chloro-5-iodopyrimidine

Catalog No.: 
ACJEPI498
CAS No.: 
118089-42-2
Molecular Formula: 
C8H10ClIN2
Molecular Weight: 
296.54
2-tert-Butyl-4-chloro-5-iodopyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$93.00In stockInquiry
250mg95%$157.00In stockInquiry
1g95%$421.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-tert-Butyl-4-chloro-5-iodopyrimidine
IUPAC Name2-(tert-butyl)-4-chloro-5-iodopyrimidine
MDL No.MFCD21744144
Molecular FormulaC8H10ClIN2
Molecular Weight296.54
SMILESIC1=CN=C(C(C)(C)C)N=C1Cl
InChI KeyLYGFPSSXCLWRMZ-UHFFFAOYSA-N
Synonym2-tert-butyl-4-chloro-5-iodopyrimidine;Pyrimidine, 4-chloro-2-(1,1-dimethylethyl)-5-iodo-
CAS No.118089-42-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJEPI498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJEPI498 route compound structure diagram
    ACJEPI498118089-42-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJEPI498 route product structure diagram
    ACJEPI498118089-42-2In Stock
Inquiry

2. ACJEPI498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJEPI498 route product structure diagram
    ACJEPI498118089-42-2In Stock
Inquiry

3. ACJEPI498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJEPI498 route product structure diagram
    ACJEPI498118089-42-2In Stock
Inquiry

Comments (0)